These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 11496385)

  • 1. Isotretinoin (roaccutane) usage--a South African consensus guideline. National Dermatology Working Group.
    S Afr Med J; 1997 Oct; 87(10 Pt 2):1410-3. PubMed ID: 11496385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose schema of isotretinoin in acne vulgaris.
    Mandekou-Lefaki I; Delli F; Teknetzis A; Euthimiadou R; Karakatsanis G
    Int J Clin Pharmacol Res; 2003; 23(2-3):41-6. PubMed ID: 15018017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roaccutane treatment guidelines: results of an international survey.
    Cunliffe WJ; van de Kerkhof PC; Caputo R; Cavicchini S; Cooper A; Fyrand OL; Gollnick H; Layton AM; Leyden JJ; Mascaró JM; Ortonne JP; Shalita A
    Dermatology; 1997; 194(4):351-7. PubMed ID: 9252756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral isotretinoin for acne, adjusting treatment according to patient's response.
    Ghaffarpour G; Mazloomi S; Soltani-Arabshahi R; Seyed KS
    J Drugs Dermatol; 2006 Oct; 5(9):878-82. PubMed ID: 17039654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose isotretinoin in acne vulgaris: improved treatment outcomes and quality of life.
    Cyrulnik AA; Viola KV; Gewirtzman AJ; Cohen SR
    Int J Dermatol; 2012 Sep; 51(9):1123-30. PubMed ID: 22909370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost-effectiveness of isotretinoin in the treatment of acne. Part 1. A meta-analysis of effectiveness literature.
    Wessels F; Anderson AN; Kropman K
    S Afr Med J; 1999 Jul; 89(7 Pt 2):780-4. PubMed ID: 10470317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost-effectiveness of isotretinoin in the treatment of acne. Part 3. A cost-minimisation pharmaco-economic model.
    Wessels F; Anderson AN; Kropman K
    S Afr Med J; 1999 Jul; 89(7 Pt 2):791-4. PubMed ID: 10470319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of acne with intermittent and conventional isotretinoin: a randomized, controlled multicenter study.
    Akman A; Durusoy C; Senturk M; Koc CK; Soyturk D; Alpsoy E
    Arch Dermatol Res; 2007 Dec; 299(10):467-73. PubMed ID: 17710426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of isotretinoin in acne therapy: why not as first-line therapy? facts and controversies.
    Rigopoulos D; Larios G; Katsambas AD
    Clin Dermatol; 2010; 28(1):24-30. PubMed ID: 20082946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isotretinoin: dose, duration and relapse. What does 30 years of usage tell us?
    Rademaker M
    Australas J Dermatol; 2013 Aug; 54(3):157-62. PubMed ID: 23013115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris.
    Blasiak RC; Stamey CR; Burkhart CN; Lugo-Somolinos A; Morrell DS
    JAMA Dermatol; 2013 Dec; 149(12):1392-8. PubMed ID: 24173086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne.
    Gollnick HP; Graupe K; Zaumseil RP
    Eur J Dermatol; 2001; 11(6):538-44. PubMed ID: 11701404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspects of roaccutane prescription in South Africa.
    Smart AJ; Walters L
    S Afr Med J; 1994 Aug; 84(8 Pt 1):497-502. PubMed ID: 7825086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An expert view on the treatment of acne with systemic antibiotics and/or oral isotretinoin in the light of the new European recommendations.
    Dréno B; Bettoli V; Ochsendorf F; Perez-Lopez M; Mobacken H; Degreef H; Layton A
    Eur J Dermatol; 2006; 16(5):565-71. PubMed ID: 17101480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the efficacies of intermittent and continuous low-dose isotretinoin regimens in the treatment of moderate acne vulgaris.
    Boyraz N; Mustak PK
    Int J Dermatol; 2013 Oct; 52(10):1265-7. PubMed ID: 23675954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of intermittent isotretinoin treatment in mild or moderate acne.
    Kaymak Y; Ilter N
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1256-60. PubMed ID: 17062042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral isotretinoin in different dose regimens for acne vulgaris: a randomized comparative trial.
    Agarwal US; Besarwal RK; Bhola K
    Indian J Dermatol Venereol Leprol; 2011; 77(6):688-94. PubMed ID: 22016276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral isotretinoin treatment policy. Do we all agree?
    Ortonne JP
    Dermatology; 1997; 195 Suppl 1():34-7; discussion 38-40. PubMed ID: 9310744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isotretinoin updates.
    On SC; Zeichner J
    Dermatol Ther; 2013; 26(5):377-89. PubMed ID: 24099068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose isotretinoin in the treatment of acne vulgaris.
    Amichai B; Shemer A; Grunwald MH
    J Am Acad Dermatol; 2006 Apr; 54(4):644-6. PubMed ID: 16546586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.